Clinical trials
No longer available Multiple Myeloma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| No longer available | 20 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| Janssen Research & Development, LLC | 3 |
| Novartis Pharmaceuticals | 2 |
| Pfizer | 2 |
| Barbara Ann Karmanos Cancer Institute | 1 |
| Celgene | 1 |
| Dana-Farber Cancer Institute | 1 |
| Genzyme, a Sanofi Company | 1 |
| Janssen-Ortho Inc., Canada | 1 |
| Masonic Cancer Center, University of Minnesota | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Multiple Myeloma | 20 |
| Recurrence | 6 |
| Hodgkin Disease | 2 |
| Lymphoma, Non-Hodgkin | 2 |
| Blast Crisis | 1 |
| Burkitt Lymphoma | 1 |
| Congenital Abnormalities | 1 |
| Dendritic Cell Sarcoma, Interdigitating | 1 |
| Immunoglobulin Light-chain Amyloidosis | 1 |
| Leukemia | 1 |
Trials
Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.